Clinical Trials Directory

Trials / Completed

CompletedNCT04446910

Using Technology to Reduce Youth Substance Use

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
79 (actual)
Sponsor
University of California, San Francisco · Academic / Other
Sex
All
Age
13 Years – 18 Years
Healthy volunteers
Not accepted

Summary

The research project will focus on conducting a trial of whether a tailored SMS text-messaging intervention is efficacious in improving justice-involved youths' substance use or dual diagnosis treatment attendance and engagement.

Detailed description

The study will demonstrate how delivery of motivational/coaching messages to justice-involved youth and their caregivers will lead to greater youth substance use treatment attendance and engagement. The study will start with identifying the feasibility and acceptability of the SMS text-messaging intervention with community-supervised justice-involved youth. Then, the study will determine whether the tailored dyadic (youth and caregiver) SMS text-messaging intervention improves justice-involved youth substance use or dual diagnosis treatment attendance and engagement relative to standard of care (not receiving motivational/coaching messages). Finally, the study will characterize patterns of key justice and behavioral health system-level factors that promote or hinder eventual adoption and sustainability of mHealth technology as a tool to improve treatment attendance for justice-involved youth.

Conditions

Interventions

TypeNameDescription
BEHAVIORALSMS Text MessagingSMS text messaging intervention for a period of 90 days to promote attendance at community-based substance use or dual diagnosis treatment appointments through motivational messages.
BEHAVIORALStandard of Care Engagement PracticesStandard of care engagement practices, such as communicating with youth and caregivers, as needed, through texting but frequency of contact and content of messaging varies according to individual needs.

Timeline

Start date
2020-05-01
Primary completion
2025-04-01
Completion
2025-04-01
First posted
2020-06-25
Last updated
2025-04-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04446910. Inclusion in this directory is not an endorsement.